|
1.
|
Shan Z, Zubcevic J, Shi P, Jun JY, Dong Y, Murça TM, Lamont GJ, Cuadra A, Yuan W, Qi Y, Li Q, Paton JF, Katovich MJ, Sumners C, Raizada MK. Chronic Knockdown of the Nucleus of the Solitary Tract AT1 Receptors Increases Blood Inflammatory-Endothelial Progenitor Cell Ratio and Exacerbates Hypertension in the Spontaneously Hypertensive Rat. Hypertension. 2013 Jun; 61(6):1328-33.
|
|
|
|
|
2.
|
Knott TK, Hussy N, Cuadra AE, Lee RH, Ortiz-Miranda S, Custer EE, Lemos JR. Adenosine Trisphosphate Appears to Act via Different Receptors in Terminals Versus Somata of the Hypothalamic Neurohypophysial System. J Neuroendocrinol. 2012 Apr; 24(4):681-9.
|
|
|
|
|
3.
|
Custer EE, Knott TK, Cuadra AE, Ortiz-Miranda S, Lemos JR. P2X Purinergic Receptor Knockout Mice Reveal Endogenous ATP Modulation of Both Vasopressin and Oxytocin Release from the Intact Neurohypophysis. J Neuroendocrinol. 2012 Apr; 24(4):674-80.
|
|
|
|
|
4.
|
Lemos JR, Ortiz-Miranda SI, Cuadra AE, Velázquez-Marrero C, Custer EE, Dad T, Dayanithi G. Modulation/physiology of calcium channel sub-types in neurosecretory terminals. Cell Calcium. 2012 Mar; 51(3-4):284-92.
|
|
|
|
|
5.
|
Shan Z, Shi P, Cuadra AE, Dong Y, Lamont GJ, Li Q, Seth DM, Navar LG, Katovich MJ, Sumners C, Raizada MK. Involvement of the brain (pro)renin receptor in cardiovascular homeostasis. Circ Res. 2010 Oct 1; 107(7):934-8.
|
|
|
|
|
6.
|
Cuadra AE, Shan Z, Sumners C, Raizada MK. A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther. 2010 Jan; 125(1):27-38.
|
|
|
|
|
7.
|
Jiang N, Shi P, Li H, Lu S, Braseth L, Cuadra AE, Raizada MK, Sumners C. Phosphate-activated glutaminase-containing neurons in the rat paraventricular nucleus express angiotensin type 1 receptors. Hypertension. 2009 Oct; 54(4):845-51.
|
|
|
|
|
8.
|
Cabadak H, Cuadra AE, El-Fakahany EE, Kan B. M2, M3, and M4 muscarinic receptors are expressed in the guinea pig gallbladder. J Recept Signal Transduct Res. 2009; 29(1):63-6.
|
|
|
|
|
9.
|
Briggs LE, Takeda M, Cuadra AE, Wakimoto H, Marks MH, Walker AJ, Seki T, Oh SP, Lu JT, Sumners C, Raizada MK, Horikoshi N, Weinberg EO, Yasui K, Ikeda Y, Chien KR, Kasahara H. Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ Res. 2008 Sep 12; 103(6):580-90.
|
|
|
|
|
10.
|
Shan Z, Cuadra AE, Sumners C, Raizada MK. Characterization of a functional (pro)renin receptor in rat brain neurons. Exp Physiol. 2008 May; 93(5):701-8.
|
|
|
|
|
11.
|
Cuadra AE, El-Fakahany EE. Mechanisms of M(1) muscarinic receptor-mediated up-regulation of neuronal nitric oxide synthase in N1E-115 neuroblastoma cells. Brain Res Mol Brain Res. 2005 Apr 4; 134(2):198-204.
|
|
|
|
|
12.
|
Cuadra AE, Kuo SH, Kawasaki Y, Bredt DS, Chetkovich DM. AMPA receptor synaptic targeting regulated by stargazin interactions with the Golgi-resident PDZ protein nPIST. J Neurosci. 2004 Aug 25; 24(34):7491-502.
|
|
|
|
|
13.
|
Otero JJ, Fu W, Kan L, Cuadra AE, Kessler JA. Beta-catenin signaling is required for neural differentiation of embryonic stem cells. Development. 2004 Aug; 131(15):3545-57.
|
|
|
|
|
14.
|
Grant MK, Cuadra AE, El-Fakahany EE. Endogenous expression of nNOS protein in several neuronal cell lines. Life Sci. 2002 Jul 5; 71(7):813-7.
|
|
|
|
|
15.
|
Gao T, Cuadra AE, Ma H, Bunemann M, Gerhardstein BL, Cheng T, Eick RT, Hosey MM. C-terminal fragments of the alpha 1C (CaV1.2) subunit associate with and regulate L-type calcium channels containing C-terminal-truncated alpha 1C subunits. J Biol Chem. 2001 Jun 15; 276(24):21089-97.
|
|
|
|
|
16.
|
Fatemi SH, Cuadra AE, El-Fakahany EE, Sidwell RW, Thuras P. Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport. 2000 May 15; 11(7):1493-6.
|
|
|
|
|
17.
|
Cuadra AE, El-Fakahany EE. Up-regulation of the neuronal form of nitric oxide synthase in response to prolonged muscarinic M1 receptor stimulation. J Neurochem. 1998 Aug; 71(2):571-9.
|
|
|
|
|
18.
|
Cuadra AE, El-Fakahany EE. Enhancement of maximal activation of neuronal nitric oxide synthase at muscarinic M1 receptors following prolonged agonist treatment. Eur J Pharmacol. 1997 Sep 3; 334(1):107-10.
|
|
|
|
